Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI

NeuroImage: Clinical

Volumn 4, Issue , 2014, Pages 182-189

  Cramer, S P ^a   Simonsen, H ^a   Frederiksen, J L ^a   Rostrup, E ^a   Larsson, H B W ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Blood brain barrier; DCE MRI; Disease modifying therapy; MRI; Multiple sclerosis; Perfusion MRI

Indexed keywords

FINGOLIMOD; GADOBUTROL; NATALIZUMAB; CONTRAST MEDIUM;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRAY MATTER; HUMAN; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RELAPSE; WHITE MATTER; CAPILLARY PERMEABILITY; DIAGNOSTIC USE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTIGRAPHY; SEVERITY OF ILLNESS INDEX; THREE DIMENSIONAL IMAGING; MEMBRANE PERMEABILITY;

ADULT; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CONTRAST MEDIA; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PERFUSION IMAGING; SEVERITY OF ILLNESS INDEX; WHITE MATTER;

EID: 84891289780     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2013.12.001     Document Type: Article

References (37)

1. C. Casiraghi, K. Dorovini-Zis, and M.S. Horwitz Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis J. Neuroimmunol. 230 2011 173 177
2. J. Correale, M. Fiol, and W. Gilmore The risk of relapses in multiple sclerosis during systemic infections Neurology 67 2006 652 659
3. N. De Stefano In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis Brain 122 1999 1933 1939
4. A. Elong Ngono, S. Pettré, M. Salou, B. Bahbouhi, J.-P. Soulillou, S. Brouard, and D.-A. Laplaud Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients Clin. Immunol. 144 2012 117 126
5. M.M. Filippi, M.A.M. Rocca, G.G. Martino, M.A.M. Horsfield, and G.G. Comi Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis Ann. Neurol. 43 1998 809 814
6. D.E. Goodkin, W.D. Rooney, R. Sloan, P. Bacchetti, L. Gee, M. Vermathen, E. Waubant, M. Abundo, S. Majumdar, S. Nelson, and M.W. Weiner A serial study of new MS lesions and the white matter from which they arise Neurology 51 1998 1689 1697
7. A.E. Hansen, H. Pedersen, E. Rostrup, and H.B.W. Larsson Partial volume effect (PVE) on the arterial input function (AIF) in T1-weighted perfusion imaging and limitations of the multiplicative rescaling approach Magn. Reson. Med. 62 2009 1055 1059
8. J.O.J. Harris, J.A.J. Frank, N.N. Patronas, D.E.D. McFarlin, and H.F.H. McFarland Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history Ann. Neurol. 29 1991 548 555
9. F. Iannotti, C. Fieschi, B. Alfano, P. Picozzi, L. Mansi, C. Pozzilli, A. Punzo, G. Del Vecchio, G.L. Lenzi, and M. Salvatore Simplified, noninvasive PET measurement of blood-brain barrier permeability J. Comput. Assist. Tomogr. 11 1987 390 397
10. M. Ingrisch, S. Sourbron, D. Morhard, B. Ertl-Wagner, T. Kümpfel, R. Hohlfeld, M. Reiser, and C. Glaser Quantification of perfusion and permeability in multiple sclerosis Investig. Radiol. 47 2012 252 258
11. A.G. Kermode, A.J. Thompson, P. Tofts, D.G. MacManus, B.E. Kendall, D.P. Kingsley, I.F. Moseley, P. Rudge, and W.I. McDonald Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications Brain 113 Pt 5 1990 1477 1489
12. J. Kirk, J. Plumb, M. Mirakhur, and S. McQuaid Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination J. Pathol. 201 2003 319 327
13. J. Kraus, K. Voigt, A.M. Schuller, M. Scholz, K.S. Kim, M. Schilling, W.R. Schäbitz, P. Oschmann, and B. Engelhardt Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro Mult. Scler. 14 2008 843 852
14. C.C. Larochelle, J.I.J. Alvarez, and A.A. Prat How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 585 2011 3770 3780
15. H.B.W. Larsson, A.E. Hansen, H.K. Berg, E. Rostrup, and O. Haraldseth Dynamic contrast-enhanced quantitative perfusion measurement of the brain usingT1-weighted MRI at 3 T J. Magn. Reson. Imaging 27 2008 754 762
16. H.B.W. Larsson, F. Courivaud, E. Rostrup, and A.E. Hansen Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 Tesla Magn. Reson. Med. 62 2009 1270 1281
17. H. Lassmann, J. van Horssen, and D. Mahad Progressive multiple sclerosis: pathology and pathogenesis Nat. Rev. Neurol. 8 2012 647 656
18. H. Lund, M. Krakauer, A. Skimminge, F. Sellebjerg, E. Garde, H.R. Siebner, O.B. Paulson, D. Hesse, and L.G. Hanson Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis PLoS ONE 8 2013 e56375
19. R. Mancuso, A. Hernis, R. Cavarretta, D. Caputo, E. Calabrese, R. Nemni, P. Ferrante, S. Delbue, and M. Clerici Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis J. Med. Virol. 82 2010 1051 1057
20. S. McQuaid, P. Cunnea, J. McMahon, and U. Fitzgerald The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis Biochem. Soc. Trans. 37 2009 329
21. A. Minagar, and J.S. Alexander Blood-brain barrier disruption in multiple sclerosis Mult. Scler. 9 2003 540 549
22. G.P. Owens, and J.L. Bennett Trigger, pathogen, or bystander: the complex nexus linking Epstein-Barr virus and multiple sclerosis Mult. Scler. 18 2012 1204 1208
23. J. Pakpoor, G. Disanto, J.E. Gerber, R. Dobson, U.C. Meier, G. Giovannoni, and S.V. Ramagopalan The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis Mult. Scler. 19 2013 162 166
24. J.J. Plumb, S.S. McQuaid, M.M. Mirakhur, and J.J. Kirk Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis Brain Pathol. 12 2002 154 169
25. C.M. Poser Pathogenesis of multiple sclerosis. A critical reappraisal Acta Neuropathol. 71 1986 1 10
26. C.M. Poser Multiple sclerosis. Observations and reflections - a personal memoir J. Neurol. Sci. 107 1992 127 140
27. C.M. Poser The role of trauma in the pathogenesis of multiple sclerosis: a review Clin. Neurol. Neurosurg. 96 1994 103 110
28. C.M. Poser Multiple sclerosis trait: the premorbid stage of multiple sclerosis. A hypothesis Acta Neurol. Scand. 109 2004 239 243
29. V.M. Runge, W. Schoerner, H.P. Niendorf, M. Laniado, D. Koehler, C. Claussen, R. Felix, and A.E. James Initial clinical evaluation of gadolinium DTPA for contrast-enhanced magnetic resonance imaging Magn. Reson. Imaging 3 1985 27 35
30. G.A. Schumacher, G. Beebe, R.F. Kibler, L.T. Kurland, J.F. Kurtzke, F. McDowell, B. Nagler, W.A. Sibley, W.W. Tourtellotte, and T.L. Willmon Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis Ann. N. Y. Acad. Sci. 122 1965 552 568
31. N.C. Silver, P.S. Tofts, M.R. Symms, G.J. Barker, A.J. Thompson, and D.H. Miller Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study Mult. Scler. 7 2001 75 82
32. D. Soon, D.R. Altmann, K.T.M. Fernando, G. Giovannoni, F. Barkhof, C.H. Polman, P. O'Connor, B. Gray, M. Panzara, and D.H. Miller A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis J. Neurol. 254 2007 306 314
33. P.S.P. Tofts Optimal detection of blood-brain barrier defects with Gd-DTPA MRI-the influences of delayed imaging and optimised repetition time Magn. Reson. Imaging 14 1995 373 380
34. M.J. van Osch, E.J. Vonken, C.J. Bakker, and M.A. Viergever Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI Magn. Reson. Med. 45 2001 477 485
35. C.M.P. Vos, J.J.G. Geurts, L. Montagne, E.S. van Haastert, L. Bö, P. van der Valk, F. Barkhof, and H.E. de Vries Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis Neurobiol. Dis. 20 2005 953 960
36. D.J. Werring The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study Brain 123 2000 1667 1676
37. S.N. Willis, C. Stadelmann, S.J. Rodig, T. Caron, S. Gattenloehner, S.S. Mallozzi, J.E. Roughan, S.E. Almendinger, M.M. Blewett, W. Bruck, D.A. Hafler, and K.C. O'Connor Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain Brain 132 2009 3318 3328